Somehow, Silicon Valley hasn’t learned from the train wreck that was Theranos. The latest rumors are that Verily, formerly Google Life Sciences, is developing a painless blood-collection gadget “using a system of exploding micro-needles and magnets,” CNBC’s Christina Farr reports. So Silicon Valley is back at trying to fix blood tests again — one of the few parts of health care that doesn’t need fixing.
The device is a prototype, Farr says, and the Verily team is still figuring out what to do with it. Mounted on a watch, the tiny needles could, say, be used to nonintrusively collect blood from patients in the hospital or monitor blood during clinical trials, according to Farr. (Verily declined to comment to Farr, and did not respond...
